Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
Tranexamic acid decreases haemorrhage in conditions such as acute trauma and menorrhoea. Between March 1, 2013, and Aug 13, 2019, we enrolled and randomly assigned 100 participants to the tranexamic acid group (n=50) or the placebo group (n=50). The study does not provide evidence that tranexamic acid prevents intracerebral haemorrhage growth
